Nanovibronix, inc. (NAOV)
Balance Sheet / TTM
Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14
ASSETS:
Current assets:
Cash and cash equivalents

1,338

2,258

2,371

184

896

1,727

2,515

3,491

4,360

82

215

51

106

532

799

1,278

1,614

1,994

2,258

2,796

90

Trade receivables

111

175

239

70

95

70

70

23

24

29

3

4

6

11

7

11

5

6

14

-

21

Trade receivables

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

18

-

Other accounts receivable and prepaid expenses

268

310

177

57

95

130

159

29

61

80

47

44

42

71

123

54

86

77

98

15

19

Inventory

121

104

102

141

144

134

78

78

76

91

82

60

67

63

59

76

71

74

53

29

35

Total current assets

1,838

2,847

2,889

452

1,230

2,061

2,822

3,621

4,521

282

347

159

221

677

988

1,419

1,776

2,151

2,423

2,858

165

Non-current assets:
Fixed assets, net

4

5

6

6

8

10

8

6

5

7

8

10

11

12

14

15

10

12

14

16

18

DEFERRED ISSUANCE COSTS

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

358

Severance pay fund

194

218

207

359

342

350

339

343

338

298

292

272

257

235

235

217

197

190

192

-

182

Long term prepaid expenses

-

-

5

-

-

4

4

5

-

222

110

5

5

-

-

-

0

-

-

-

-

Total non-current assets

198

223

218

365

350

364

351

354

344

527

410

287

273

-

-

-

207

-

-

-

-

SEVERANCE PAY FUND

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

177

-

Total assets

2,036

3,070

3,107

817

1,580

2,425

3,173

3,975

4,865

809

757

446

494

924

1,237

1,651

1,983

2,353

2,629

3,051

723

LIABILITIES AND STOCKHOLDERS' EQUITY:
Current liabilities:
Trade payables

129

186

343

230

193

143

76

40

168

357

223

123

82

69

28

43

58

39

39

89

101

Other accounts payable and accrued expenses

280

-

-

-

447

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other accounts payable and accrued expenses

-

286

522

321

-

439

435

543

629

576

531

508

483

334

289

286

239

231

226

-

702

Due to related party

-

50

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Derivative Liability - Warrants

-

-

-

151

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Convertible Promissory notes (Note 7)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

4,617

Other accounts payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

345

-

Convertible Promissory notes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,500

-

Total current liabilities

409

522

865

702

640

582

511

583

797

933

754

631

565

403

317

329

297

270

265

1,934

5,420

Non-current liabilities:
Warrants to purchase Common stock (Notes 8, 10i)

-

-

-

-

-

-

-

-

-

2,372

1,948

2,114

2,079

1,887

1,843

1,697

1,696

1,386

698

-

734

Accrued severance pay

279

318

307

498

477

457

442

438

434

399

393

370

349

237

237

231

199

192

194

-

185

Convertible notes net of discount of $225 and derivative liabilities

-

-

-

86

-

-

-

-

-

1,394

713

134

-

-

-

-

-

-

-

-

-

Warrants to purchase Common stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

709

-

Accrued severance pay

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

179

-

Total non-current liabilities

-

318

307

584

-

1,039

442

438

1,231

4,165

3,054

2,618

2,428

2,124

2,080

1,928

1,895

1,578

892

888

919

Total liabilities

688

840

1,172

1,286

1,117

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

COMMITMENTS AND CONTINGENCIES (Note 11)

-

-

-

-

-

0

0

0

-

0

0

0

0

0

0

0

0

0

0

0

0

Stockholders' equity:
Common stock of $0.001 par value - Authorized: 24,000,000 shares at December 31, 2019 and 2018; Issued and outstanding: 4,203,764 and 3,801,522 shares at December 31, 2019 and 2018, respectively

5

5

4

4

4

4

4

4

4

2

2

2

2

2

2

2

2

2

2

0

0

Additional paid in capital

39,669

39,358

38,249

34,740

32,993

32,719

32,209

32,119

32,010

22,448

22,087

21,487

20,073

19,838

19,675

19,619

19,521

19,454

19,382

-

11,234

Additional paid-in capital

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

17,706

-

Accumulated deficit

-38,330

-37,137

-36,322

-35,215

-32,536

-31,339

-29,995

-29,171

-28,382

-26,741

-25,142

-24,294

-22,576

-21,445

-20,839

-20,229

-19,734

-18,953

-17,914

-17,480

-16,850

Total stockholders' equity

1,348

2,230

1,935

-469

463

1,386

2,220

2,954

3,634

-4,289

-3,051

-2,803

-2,499

-1,603

-1,160

-606

-209

505

1,472

229

-5,616

Total liabilities and stockholders' equity

2,036

3,070

3,107

817

1,580

2,425

3,173

3,975

4,865

809

757

446

494

924

1,237

1,651

1,983

2,353

2,629

3,051

723

Series C Preferred Stock [Member]
Preferred stock value

2

2

2

2

2

-

-

-

2

-

-

-

-

-

-

-

-

-

-

-

-

Total stockholders' equity

2

-

-

-

2

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Series E Preferred Stock [Member]
Preferred stock value

2

2

2

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total stockholders' equity

2

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-